Home Administrative Billing & Reimbursement BlueCard® Health and Wellness Medical PEAR portal Pharmacy Products Quality Management

Upcoming changes to our medical policy on sleep disorder testing

May 31, 2013

Beginning September 1, 2013, IBC will provide coverage for sleep studies as follows: Precertification will be required for facility-based sleep studies and facility-based continuous positive airway pressure (CPAP) titration studies based on the medical necessity criteria outlined in the upcoming Medical Policy #07.03.05o: Sleep Disorder Testing. Sleep studies that are conducted in the home setting will not require precertification. CPAP titration in the home setting will continue to require precertification based on the applicable rules for rental of durable medical equipment (DME). These changes are being made due to medical advances in home sleep study testing.[]1-5[] Use the []Find a Doctor[] tool to find a list of IBC-participating home-based sleep study providers and DME suppliers. [

]Upcoming changes[

] Effective for dates of service on or after September 1, 2013, precertification for commercial HMO and PPO members for sleep studies and CPAP titration in the facility setting (freestanding sleep study center or hospital sleep study lab) will be required. This change will also be implemented for Medicare Advantage HMO and PPO members effective January 1, 2014. IBC has delegated the responsibility for precertification of sleep studies and CPAP titration studies in the facility setting to AIM Specialty Health[]SM[] (AIM), an independent company. AIM will use their Sleep Disorder Management Diagnostic & Treatment Guidelines, adopted by IBC and available on the []AIM website[] to determine the most appropriate settings for these services for our members. The AIM guidelines involve integration of medical information from multiple sources to support the use of high-quality sleep management services. The process for criteria development is based on technology assessment and peer-reviewed medical literature, including clinical outcomes research and consensus opinion in current medical practice. It takes into consideration recommendations from the American Academy of Sleep Medicine, American Thoracic Society, Agency for Healthcare Research and Quality, and Centers for Medicare & Medicaid Services. Members should obtain sleep studies and CPAP titration in the setting that is most appropriate for their condition, based on factors such as: the setting that has been determined to be both safe and cost-effective for the member; the level of care required by the member during the sleep study, based on his or her medical history and current health status; current standards in medical practice. Member cost-sharing (i.e., deductible, coinsurance, and/or copayment) applies in accordance with the terms of the member's benefits contract. [

]Advantages of home-based sleep studies[

] Home sleep studies offer high value in a low-cost setting. Evidence shows that home-based sleep studies in select patient populations are equivalent in accuracy to facility-based sleep studies . and are more cost-effective.[]1-5[] Furthermore, many patients prefer the convenience of receiving the sleep study monitoring in their home. Providers should discuss this option with their patients, when appropriate. Typically, only those patients with significant comorbidities or who are suspected to have a sleep disorder other than obstructive sleep apnea (OSA) require a higher level of care during the testing at an outpatient sleep study facility or hospital. Most patients can safely undergo the sleep study and CPAP titration in their home. When performed properly, at-home sleep studies using an appropriate portable monitor can accurately diagnose most adult patients with a high pretest probability of moderate-to-severe OSA.[]1-5[] [

]Obtaining precertification for sleep studies in a facility setting[

] Providers who request coverage for administration of a sleep study in a facility setting will be required to submit details about the member?s medical history to support the request, in accordance with the revised Medical Policy. All precertification requests for sleep studies and CPAP titration in a facility setting should be submitted through the AIM ProviderPortal[]SM[], which can be accessed through the NaviNet[]?[] web portal by selecting Authorizations from the Plan Transactions menu, then AIM. Providers can also call []1-800-ASK-BLUE[]. Please note that you should continue to submit precertification requests for CPAP titration in the home setting directly to IBC. It is very important that providers use NaviNet to verify member-specific requirements or refer to the most current []precertification requirement lists[]. Failure to obtain precertification for any of the services that require it may result in a reduction in payment or nonpayment for the services not precertified. If you have any questions about these upcoming changes to place-of-service options for sleep studies, please call Customer Service at []1-800-ASK-BLUE[]. [

]References[

] [

] []1[] Rosen CL, Auckley D, Benca R, et al. A multisite randomized trial of portable sleep studies and positive airway pressure autotitration versus laboratorybased polysomnography for the diagnosis and treatment of obstructive sleep apnea: the HomePAP study. Sleep. 2012 Jun 1;35(6):757-67.[
] []2[] Masa JF, Corral J, Pereira R, et al. Effectiveness of home respiratory polygraphy for the diagnosis of sleep apnoea and hypopnoea syndrome. Thorax. 2011 Jul;66(7):567-73.[
] []3[] Domingo C, Vigil L. Effectiveness of unattended ambulatory sleep studies for the diagnosis and treatment of OSAS. J Eval Clin Pract. 2011 Feb;17(1):26-31.[
] []4[] Deutsch PA, Simmons MS, Wallace JM. Cost-effectiveness of split-night polysomnography and home studies in the evaluation of obstructive sleep apnea syndrome. J Clin Sleep Med. 2006 Apr 15;2(2):145-53.[
] []5[] Collop N, Anderson M, Boehlecke B, et al. Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adult patients. Journal of Clinical Sleep Medicine. 2007;3(7): 737-747.[

] [

NaviNet® is a registered trademark of NaviNet, Inc., an independent company.

]

This content was prepared for the Provider News Center and may not be reproduced in any way without the express written permission of Independence Blue Cross. Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association.
Connect with us     Facebook     Twitter     Flickr     YouTube     Walk the Talk    Independence Pinterest    Independence LinkedIn    Independence Instagram Site Map        Anti-Fraud        Privacy Policy        Legal        Disclaimer
© 2023 Independence Blue Cross.
Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association, serving the health insurance needs of Philadelphia and southeastern Pennsylvania.